Headquarters
575 VIRGINIA RD STE 201, CONCORD, MA 01742-2761, US
CONCORD, MA, US
From the company
ITF Therapeutics LLC is the United States rare disease affiliate of Italfarmaco S.p.A., established in January 2024 with headquarters in Concord, MA, to develop and commercialize rare disease treatments in the United States. It secured FDA approval for its first product within six months of launch and reached well over a thousand US patients with commercial supply by its first anniversary.
575 VIRGINIA RD STE 201, CONCORD, MA 01742-2761, US
Quantities, certifications, and timing.